GB9109913D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9109913D0
GB9109913D0 GB919109913A GB9109913A GB9109913D0 GB 9109913 D0 GB9109913 D0 GB 9109913D0 GB 919109913 A GB919109913 A GB 919109913A GB 9109913 A GB9109913 A GB 9109913A GB 9109913 D0 GB9109913 D0 GB 9109913D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919109913A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IAF BioChem International Inc filed Critical IAF BioChem International Inc
Priority to GB919109913A priority Critical patent/GB9109913D0/en
Publication of GB9109913D0 publication Critical patent/GB9109913D0/en
Priority to IL10050291A priority patent/IL100502A/en
Priority to IE920004A priority patent/IE73642B1/en
Priority to MD95-0086A priority patent/MD1224C2/en
Priority to ES92901354T priority patent/ES2070628T3/en
Priority to CA002100269A priority patent/CA2100269C/en
Priority to TJ94000150A priority patent/TJ249B/en
Priority to AU11534/92A priority patent/AU660650B2/en
Priority to AT92901354T priority patent/ATE120644T1/en
Priority to DE69201948T priority patent/DE69201948T2/en
Priority to US09/585,431 priority patent/USRE39155E1/en
Priority to PCT/CA1992/000001 priority patent/WO1992011852A1/en
Priority to DK92901354.8T priority patent/DK0565549T3/en
Priority to PH43730A priority patent/PH31397A/en
Priority to GEAP19922644A priority patent/GEP19981482B/en
Priority to EP92300056A priority patent/EP0494119A1/en
Priority to US08/084,222 priority patent/US5532246A/en
Priority to JP4501365A priority patent/JP2659863B2/en
Priority to CA002254613A priority patent/CA2254613A1/en
Priority to EP92901354A priority patent/EP0565549B1/en
Priority to TW081102738A priority patent/TW202385B/zh
Priority to KR1019930701998A priority patent/KR0156747B1/en
Priority to NO932442A priority patent/NO180407C/en
Priority to EE9400302A priority patent/EE02995B1/en
Priority to GR940402226T priority patent/GR3015694T3/en
Priority to HK159395A priority patent/HK159395A/en
Priority to CY9802047A priority patent/CY2047B1/en
Pending legal-status Critical Current

Links

GB919109913A 1991-01-03 1991-05-07 Medicaments Pending GB9109913D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB919109913A GB9109913D0 (en) 1991-05-07 1991-05-07 Medicaments
IL10050291A IL100502A (en) 1991-01-03 1991-12-25 Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
IE920004A IE73642B1 (en) 1991-01-03 1992-01-02 Medicaments
EP92901354A EP0565549B1 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b
DK92901354.8T DK0565549T3 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolannucleoside analogues for the preparation of a preparation for the treatment of hepatitis B
US08/084,222 US5532246A (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
CA002100269A CA2100269C (en) 1991-01-03 1992-01-03 Use of 1, 3-oxathiolane nucleoside analogues in the treatment of hepatitis b
TJ94000150A TJ249B (en) 1991-01-03 1992-01-03 1,3-Oxathiolane nucleoside analogues their use
AU11534/92A AU660650B2 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
AT92901354T ATE120644T1 (en) 1991-01-03 1992-01-03 USE OF 1,3-OXATHIOL ANALOGUES OF NUCLEOSIDES FOR PRODUCING A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS-B.
DE69201948T DE69201948T2 (en) 1991-01-03 1992-01-03 USE OF 1,3-OXATHIOL ANALOGS OF NUCLEOSIDES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING HEPATITIS-B.
US09/585,431 USRE39155E1 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
PCT/CA1992/000001 WO1992011852A1 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b
MD95-0086A MD1224C2 (en) 1991-01-03 1992-01-03 Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
PH43730A PH31397A (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in thetreatment of hepatitis b.
GEAP19922644A GEP19981482B (en) 1991-01-03 1992-01-03 Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
EP92300056A EP0494119A1 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
ES92901354T ES2070628T3 (en) 1991-01-03 1992-01-03 USE OF COMPOUNDS ANALOGED TO 1,3-OXATIOLANE-NUCLEOSIDES IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS B.
JP4501365A JP2659863B2 (en) 1991-01-03 1992-01-03 Use of 1,3-oxathiolane nucleoside analogs for the treatment of hepatitis B
CA002254613A CA2254613A1 (en) 1991-01-03 1992-01-03 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b
TW081102738A TW202385B (en) 1991-01-03 1992-04-09
KR1019930701998A KR0156747B1 (en) 1991-01-03 1993-07-02 Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
NO932442A NO180407C (en) 1991-01-03 1993-07-05 Use of 1,3-oxathiolannucleoside analogues in the manufacture of a medicament for the treatment of hepatitis B
EE9400302A EE02995B1 (en) 1991-01-03 1994-10-20 Use of 1,3-oxathiolane nucleoside analogues for the preparation of hepatitis B drugs
GR940402226T GR3015694T3 (en) 1991-01-03 1995-04-06 Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b.
HK159395A HK159395A (en) 1991-01-03 1995-10-12 Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b
CY9802047A CY2047B1 (en) 1991-01-03 1998-04-30 Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919109913A GB9109913D0 (en) 1991-05-07 1991-05-07 Medicaments

Publications (1)

Publication Number Publication Date
GB9109913D0 true GB9109913D0 (en) 1991-07-03

Family

ID=10694614

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919109913A Pending GB9109913D0 (en) 1991-01-03 1991-05-07 Medicaments

Country Status (1)

Country Link
GB (1) GB9109913D0 (en)

Similar Documents

Publication Publication Date Title
HK1004711A1 (en) Medicaments
IL102322A0 (en) Medicaments
AP9100339A0 (en) Medicaments
GB9121204D0 (en) Medicament
GB9115740D0 (en) Medicaments
GB9121463D0 (en) Medicament
GB9122051D0 (en) Medicines
GB9104650D0 (en) Medicaments
GB9108348D0 (en) Medicaments
ZA927925B (en) Medicaments
GB9122473D0 (en) Medicaments
GB9126444D0 (en) Medicaments
GB9113787D0 (en) Medicaments
GB9113381D0 (en) Medicaments
GB9116687D0 (en) Medicaments
GB9117943D0 (en) Medicaments
GB9122472D0 (en) Medicaments
ZA929617B (en) Medicaments
GB9113383D0 (en) Medicaments
GB9109913D0 (en) Medicaments
GB9113379D0 (en) Medicaments
GB9100039D0 (en) Medicaments
ZA924524B (en) Medicaments
GB9105774D0 (en) Medicaments
GB9111901D0 (en) Medicaments